Patient Compliance

Polyethylene glycol (PEG) 3350 is a safe and effective long-term laxative in pediatric populations, but only limited studies are available for its use in children younger than two years of age.

No H1N1 products authorized for sale in Canada

New hospitals bring more registrations

Phone system supports multidisciplinary program

Built to evidence-based design standards

eHealth Ontario has launched Canada's first electronic prescribing program, a demonstration project it hopes to have in place province-wide by 2012.

Health Canada and Hoffmann-La Roche have issued an advisory concerning potentially serious adverse effects in association with erlotinib.

Drive-through dispensaries are distracting and lead to delays and dispensing errors, found a U.S.-based study by Ohio State University (OSU) researchers.

Reports benefits in dealing with chronic diseases